Loading organizations...
Loading organizations...
Specialty pharmaceutical developing treatments for neurodegenerative disord
Annovis Bio has raised $7.1M across 4 funding rounds.
Annovis Bio has raised $7.1M in total across 4 funding rounds.
Annovis Bio has raised $7.1M in total across 4 funding rounds.
Annovis Bio's investors include Robin Hood Ventures, Michael Hoffman, Delaware Crossing Investor Group, Keiretsu Forum, Ben Franklin Technology Partners of Southeastern Pennsylvania, BioAdvance.
Annovis Bio has raised $7.1M across 4 funding rounds. Most recently, it raised $800K Series A in October 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 28, 2016 | $800K Series A | Robin Hood Ventures | |
| May 26, 2015 | $5.7M Series A | Michael Hoffman | Delaware Crossing Investor Group, Keiretsu Forum, Robin Hood Ventures |
| Jan 17, 2012 | $110K Other Equity | Ben Franklin Technology Partners of Southeastern Pennsylvania | |
| Jun 2, 2010 | $500K Seed | BioAdvance |